Pfizer (PFE)
(Delayed Data from NYSE)
$24.65 USD
+0.36 (1.48%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $24.67 +0.02 (0.08%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Pfizer Inc. has a market cap of $138.10B, which represents its share price of $24.29 multiplied by its outstanding shares number of 5.69B. As a large-cap company, PFE's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PFE 24.65 +0.36(1.48%)
Will PFE be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for PFE
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View
What Analyst Projections for Key Metrics Reveal About Pfizer (PFE) Q3 Earnings
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
Other News for PFE
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week
Trending stocks this week: Wall Street extends rally on Big Tech earnings, trade optimism, Fed rate cut
Dividend Champion, Contender, And Challenger Highlights: Week Of November 2
What You Missed On Wall Street On Friday
Palantir, Qualcomm Set To Report Earnings